Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival-Reference-Cited by-同舟云学术

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Published:2022-09-05 Issue:19 Volume:13 Page:2776-2785
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Masubuchi Ken¹,Imai Hisao¹²^ORCID,Wasamoto Satoshi³,Tsuda Takeshi⁴,Minemura Hiroyuki⁵^ORCID,Nagai Yoshiaki⁶,Yamada Yutaka⁷^ORCID,Kishikawa Takayuki⁸^ORCID,Umeda Yukihiro⁹,Shiono Ayako²,Takechi Hiroki³,Shiihara Jun⁶,Kaira Kyoichi²^ORCID,Kanazawa Kenya⁵,Taniguchi Hirokazu⁴^ORCID,Kaburagi Takayuki⁷,Kagamu Hiroshi²,Minato Koichi¹

Affiliation:

1. Division of Respiratory Medicine, Gunma Prefectural Cancer Center Ota Japan

2. Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center Saitama Medical University Hidaka Japan

3. Division of Respiratory Medicine, Saku Central Hospital Advanced Care Center Saku Japan

4. Division of Respiratory Medicine, Toyama Prefectural Central Hospital Toyama Japan

5. Department of Pulmonary Medicine Fukushima Medical University Fukushima Japan

6. Department of Respiratory Medicine Jichi Medical University, Saitama Medical Center Saitama Japan

7. Division of Respiratory Medicine, Ibaraki Prefectural Central Hospital Kasama Japan

8. Division of Thoracic Oncology, Tochigi Cancer Center Utsunomiya Japan

9. Third Department of Internal Medicine, Faculty of Medical Sciences University of Fukui Eiheiji Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14621

Reference35 articles.

1. Cancer Statistics, 2021

2. Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

3. Small Cell Lung Cancer

4. Basic treatment considerations using chemotherapy for patients with small cell lung cancer

5. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous immunotherapy beyond progression in clinical practice for small cell lung cancer;Thoracic Cancer;2024-04-16

2. Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum–Etoposide Chemotherapy;Drugs & Aging;2023-05-05

3. Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study;Cancers;2023-02-28